[1]
Vawhal, P.K. and Jadhav, S.B. 2022. Design, synthesis, and biological evaluation of 3-chloro-2-oxo-N-(arylcarbamoyl)-2H-1-benzopyran-6-sulfonamide derivatives as potential DPP-IV inhibitors. International journal of health sciences. 6, S3 (Mar. 2022), 373–392. DOI:https://doi.org/10.53730/ijhs.v6nS3.5190.